Kwangsik Park

Prof. Dr. Kwangsik Park

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
KPKwangsik Park
Kwangsik Park
EPEun-Jung Park
Eun-Jung Park
ICIn Koo Chun
In Koo Chun
KCKyunghee Choi
Kyunghee Choi
SLSang Hee Lee
Sang Hee Lee
BLByung Chun Lee
Byung Chun Lee

12 February 2015 in Journal of Toxicology and Environmental Health, Part A
Verified
Journal Article
Closed access
JCJonghye Choi
Jonghye Choi
HKHeyjin Kim
Heyjin Kim
PKPilje Kim
Pilje Kim
EJEunhye Jo
Eunhye Jo
HKHyun-Mi Kim
Hyun-Mi Kim
KPKwangsik Park
Kwangsik Park
Toxicokinetics of zinc oxide nanoparticles (ZnONP) was studied in rats via a single intravenous (iv) injection and a single oral administration (3 mg/kg or 30 mg/kg), respectively. Blood concentrations of zinc (Zn) were monitored for 7 d and tissue distribution were determined in liver, kidneys, lung, spleen, thymus, brain, and testes. To ascertain the excretion of ZnONP, Zn levels in urine and feces were measured for 7 d. ZnONP were not readily absorbed from the gastrointestinal tract (GIT) after oral administration and were excreted mostly in feces. When the nanoparticles were injected iv to rats at a dose of 30 mg/kg, peak concentration appeared at 5 min but returned to normal range by d 2 (48 h after injection). ZnONP were distributed mainly to liver, kidneys, lung, and spleen, but not to thymus, brain, and testes. The distribution level was significantly decreased to normal by d 7. Feces excretion levels after iv injection supported biliary excretion of ZnONP. In rats injected iv with 30 mg/kg, mitotic figures in hepatocytes were significantly increased and multifocal acute injuries with dark brown pigment were noted in lungs, while no significant damage was observed in rats treated orally with the same dosage.

15 May 2007 in Environmental Monitoring and Assessment
Verified
Journal Article
Closed access
PDF file
EPEun-Jung Park
Eun-Jung Park
DKDae-Seon Kim
Dae-Seon Kim
KPKwangsik Park
Kwangsik Park

19 March 2013 in Nanotoxicology
Verified
Journal Article
Closed access
JHJeong-Sup Hong
Jeong-Sup Hong
SKSuhyon Kim
Suhyon Kim
SLSang Hee Lee
Sang Hee Lee
EJEunhye Jo
Eunhye Jo
BLByungcheun Lee
Byungcheun Lee
KPKwangsik Park
Kwangsik Park
Combined repeated-dose toxicity study of citrate-capped silver nanoparticles (7.9 ± 0.95 nm) with reproduction/developmental toxicity was investigated in rats orally treated with 62.5, 125 and 250 mg/kg, once a day for 42 days for males and up to 52 days for females. The test was performed based on the Organization for Economic Cooperation and Development test guideline 422 and Good Laboratory Practice principles. No death was observed in any of the groups. Alopecia, salivation and yellow discolouration of the lung were observed in a few rats but the symptoms were not dose-dependent. Haematology, serum biochemical investigation and histopathological analysis revealed no statistically significant differences between control group and the treated groups. Toxicity endpoints of reproduction/developmental screening test including mating, fertility, implantation, delivery and foetus were measured. There was no evidence of toxicity.

17 January 2013 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
KPKwangsik Park
Kwangsik Park
GTGeorge Tuttle
George Tuttle
FCFederico Sinche Chele
Federico Sinche Chele
SHStacey Harper
Stacey Harper

18 July 2019 in Particle and Fibre Toxicology
Verified
Journal Article
Open access
PDF file
JLJinsoo Lee
Jinsoo Lee
JJJi-Seong Jeong
Ji-Seong Jeong
SKSang Yun Kim
Sang Yun Kim
MPMin-Kyu Park
Min-Kyu Park
Sung-Deuk  ChoiSung-Deuk Choi
Sung-Deuk Choi
WYWook-Joon Yu
Wook-Joon Yu
Titanium dioxide (TiO2) nanoparticles are among the most manufactured nanomaterials in the industry, and are used in food products, toothpastes, cosmetics and paints. Pregnant women as well as their conceptuses may be exposed to TiO2 nanoparticles; however, the potential effects of these nanoparticles during pregnancy are controversial, and their internal distribution has not been investigated. Therefore, in this study, we investigated the potential effects of oral exposure to TiO2 nanoparticles and their distribution during pregnancy. TiO2 nanoparticles were orally administered to pregnant Sprague-Dawley rats (12 females per group) from gestation days (GDs) 6 to 19 at dosage levels of 0, 100, 300 and 1000 mg/kg/day, and then cesarean sections were conducted on GD 20. In the maternal and embryo-fetal examinations, there were no marked toxicities in terms of general clinical signs, body weight, food consumption, organ weights, macroscopic findings, cesarean section parameters and fetal morphological examinations. In the distribution analysis, titanium contents were increased in the maternal liver, maternal brain and placenta after exposure to high doses of TiO2 nanoparticles. Oral exposure to TiO2 during pregnancy increased the titanium concentrations in the maternal liver, maternal brain and placenta, but these levels did not induce marked toxicities in maternal animals or affect embryo-fetal development. These results could be used to evaluate the human risk assessment of TiO2 nanoparticle oral exposure during pregnancy, and additional comprehensive toxicity studies are deemed necessary considering the possibility of complex exposure scenarios and the various sizes of TiO2 nanoparticles.